DECEMBER 2017 Review now available, followed by the 2017 Annual Deal Watch Review which will be published shortly…..
The licensing process is multidirectional. In the case of biotech companies, they are seeking development and commercialisation partners. However for marketing companies, they are seeking new products and technologies to supplement the portfolio either on a global or local basis. At Medius we have considerable experience of working on both in and out licensing assignments.
The chances of success are greatly enhanced if the technology is sold into the potential partner company via the right portal. Medius has an unrivalled network of contacts throughout the business development community and can identify the correct entry point for taking technologies and products into companies as well as for finding new product opportunities.